BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
53.33M
Enterprise Value 3
58.72M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
34.10
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
37.55
Enterprise Value/EBITDA 6
-9.47

Trading Information

Stock Price History

Beta (3Y Monthly) -0.34
52-Week Change 343.20%
S&P500 52-Week Change 39.10%
52 Week High 30.4000
52 Week Low 30.1100
50-Day Moving Average 30.2786
200-Day Moving Average 30.2420

Share Statistics

Avg Vol (3 month) 3231.05k
Avg Vol (10 day) 3381.12k
Shares Outstanding 5157.38M
Float 117.78M
% Held by Insiders 126.97%
% Held by Institutions 10.08%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4May 28, 1997
Last Split Factor (new per old) 225/1
Last Split Date 3Mar 21, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-400.13%

Management Effectiveness

Return on Assets (ttm)-164.66%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.56M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)30.30%
Gross Profit (ttm)621k
EBITDA -6.2M
Net Income Avi to Common (ttm)-8.77M
Diluted EPS (ttm)-0.0630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)706k
Total Cash Per Share (mrq)0
Total Debt (mrq)4.16M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.22
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-3.69M
Levered Free Cash Flow (ttm)-1.18M